PRNewsWire
22 Jul 2026, 18:35 UTC · 3h ago
THUNDER Study Demonstrates Penumbra's THUNDERBOLT is Safe and Effective for Stroke Care
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
PRNewsWire
22 Jul 2026, 18:35 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
The THUNDER study demonstrated that the THUNDERBOLT system achieved an 87.5% successful reperfusion rate in stroke patients with emergent large vessel occlusion. — High efficacy rates in clinical trials for a core product typically drive revenue growth and increase market share.
+0.60The THUNDERBOLT system has recently received U.S. FDA clearance and the CE Mark. — Regulatory approval is a critical milestone that allows for immediate commercialization and sales in major global markets.
+0.50THUNDERBOLT is the first and only computer assisted vacuum thrombectomy (CAVT) device for stroke to demonstrate these revascularization and safety rates. — Establishing a unique technological advantage or 'first-mover' status creates a competitive moat against other medical device companies.
+0.40Which stocks this story touches
Continue reading
6 related stories
Search tags
The company announced successful clinical study results demonstrating the safety and effectiveness of its THUNDERBOLT system for stroke care.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
11h ago
